Category: Emerging Infectious Diseases
Jinja registers two more Ebola cases
(Monitor) Two more Ebola cases have been confirmed in Jinja District, according to the Deputy Resident District Commissioner, Mr Mohammed Kigongo. Mr Kigongo said the victims include the daughter of Dan Waiswa, who succumbed to Ebola last week, and her 18-month-old daughter, both residents of Kayalwe B village in Buyengo Town Council.
Nov 15, 2022
Soaring Infant Lung Illnesses Spur Race for Prevention
(Bloomberg) Doctors and parents are looking to new drugs and vaccines on the horizon to prevent a lung virus that’s been filling pediatric emergency rooms earlier than usual this season. Trial results this month from Pfizer Inc.’s maternal vaccine for respiratory syncytial virus, or RSV, and a European regulatory win for Sanofi and AstraZeneca Plc’s antibody that prevents the disease for a […]
Nov 15, 2022
Two people, both over 65, die of RSV in NY State
(Local News) Health leaders said there have been more than 2,200 lab-confirmed RSV cases in the county, mostly babies and toddlers. The virus puts about 80,000 children in the hospital in the U.S. every year but it can also harm older people. “For three years, all these babies being born, none of them get infected […]
Nov 15, 2022
Covid Hospitalizations Are Rising in Kids Under 6 Months, CDC Director Walensky Says
(Bloomberg) Covid-19 hospitalizations are rising among babies under 6 months old, and the US Centers for Disease Control and Prevention is urging mothers to get vaccinated to reduce the risk of infection in those not yet eligible for shots, Director Rochelle Walensky said. “We’re seeing more and more of those younger babies getting hospitalized,” Walensky […]
Nov 15, 2022
RSV Is Bad. Where’s the Vaccine?
(WSJ Podcast) Every winter, the respiratory virus RSV lands tens of thousands of babies and young children in hospitals around the country. This year, the outbreak started early. WSJ’s Denise Roland explains the challenges of creating an RSV vaccine.
Nov 15, 2022
Pfizer nabs RSV therapeutic biotech ReViral in quick $525M bolt-on
(Fierce Biotech) Pfizer has had plenty of success in respiratory syncytial virus (RSV) lately, with multiple FDA designations and clinical advancements for its vaccine candidate. But that’s not enough for the pharma giant. Today, the New York-based behemoth is acquiring ReViral and its collection of therapeutics for the pesky respiratory virus for $525 million.
Nov 15, 2022
RSV antibody from Sanofi and AstraZeneca approved in Europe
(Chemical and Engineering News) With the first vaccines to guard against respiratory syncytial virus (RSV) expected to receive regulatory approval in the months ahead, the European Commission earlier this month gave its nod to a monoclonal antibody developed by Sanofi and AstraZeneca to prevent RSV lower respiratory tract illness (LRTI) in newborns and infants. The […]
Nov 15, 2022
RSV hospitalization rate for seniors is 10 times higher than usual for this point in the season
(CNN Video) The respiratory virus season has started early in kids this year and flooded children’s hospitals in many parts of the country – especially with respiratory syncytial virus, known as RSV. But adults can get RSV, too. Although RSV does not typically send as many adults to the hospital, it can be a serious and even deadly […]
Nov 15, 2022
RSV hospitalizations triple in recent weeks in Oregon
(Local News) Oregon Gov. Kate Brown issued an executive order Monday in response to the surge of pediatric cases and hospitalizations of respiratory viruses, including Respiratory Syncytial Virus. Cases of the virus, commonly known as RSV, have been rising across Oregon for the last four weeks. Brown said this executive order will give hospitals more […]
Nov 15, 2022
California child dies of flu and RSV as cases soar, hospitals threatened
(Los Angeles Times) Flu season has roared to life in California, reaching levels not seen in years and threatening to further strain a healthcare system already contending with an onslaught of RSV cases and still-potent circulation of the coronavirus. Underscoring the worrisome conditions, California Department of Public Health officials on Monday reported the season’s first death of […]
Nov 15, 2022